chr6-32444611-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_019111.5(HLA-DRA):​c.*12-41T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.489 in 151,926 control chromosomes in the GnomAD database, including 18,793 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 18793 hom., cov: 31)
Exomes 𝑓: 0.50 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

HLA-DRA
NM_019111.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0970

Publications

14 publications found
Variant links:
Genes affected
HLA-DRA (HGNC:4947): (major histocompatibility complex, class II, DR alpha) HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. This molecule is expressed on the surface of various antigen presenting cells such as B lymphocytes, dendritic cells, and monocytes/macrophages, and plays a central role in the immune system and response by presenting peptides derived from extracellular proteins, in particular, pathogen-derived peptides to T cells. The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.645 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_019111.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLA-DRA
NM_019111.5
MANE Select
c.*12-41T>G
intron
N/ANP_061984.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLA-DRA
ENST00000395388.7
TSL:6 MANE Select
c.*12-41T>G
intron
N/AENSP00000378786.2
HLA-DRA
ENST00000374982.5
TSL:6
c.*12-41T>G
intron
N/AENSP00000364121.5
ENSG00000299747
ENST00000766007.1
n.163-6351A>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.489
AC:
74196
AN:
151808
Hom.:
18783
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.512
Gnomad AMI
AF:
0.386
Gnomad AMR
AF:
0.563
Gnomad ASJ
AF:
0.685
Gnomad EAS
AF:
0.664
Gnomad SAS
AF:
0.601
Gnomad FIN
AF:
0.297
Gnomad MID
AF:
0.668
Gnomad NFE
AF:
0.456
Gnomad OTH
AF:
0.525
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.500
AC:
2
AN:
4
Hom.:
0
Cov.:
0
AF XY:
0.500
AC XY:
2
AN XY:
4
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
1
AN:
2
Other (OTH)
AF:
0.500
AC:
1
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.400
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.489
AC:
74242
AN:
151926
Hom.:
18793
Cov.:
31
AF XY:
0.486
AC XY:
36129
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.511
AC:
21179
AN:
41414
American (AMR)
AF:
0.563
AC:
8601
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.685
AC:
2374
AN:
3464
East Asian (EAS)
AF:
0.664
AC:
3425
AN:
5162
South Asian (SAS)
AF:
0.601
AC:
2895
AN:
4814
European-Finnish (FIN)
AF:
0.297
AC:
3131
AN:
10550
Middle Eastern (MID)
AF:
0.663
AC:
195
AN:
294
European-Non Finnish (NFE)
AF:
0.456
AC:
30977
AN:
67942
Other (OTH)
AF:
0.529
AC:
1115
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1860
3721
5581
7442
9302
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
684
1368
2052
2736
3420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.477
Hom.:
7232

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
7.0
DANN
Benign
0.55
PhyloP100
-0.097
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4935356; hg19: chr6-32412388; API